Search Results

You are looking at 1 - 10 of 998 items for :

Clear All
Open access

Bhaskar Dawane, Shankaraiah Konda, Baseer Shaikh and Raghunath Bhosale

References J. R. Dimmock, D. W. Elias, M. A. Beazely and N. M. Kandepu, Bioactivities of chalcones, Curr. Med. Chem. 6 (1999) 1125-1150. M. L. Go, X. Wu and L. X. Liu, Chalcones: An update on cytotoxic and chemoprotective properties, Curr. Med. Chem. 12 (2005) 483-499. Z. Nowakowka, A review of anti-infective and anti-inflammatory chalcones, Eur. J. Med. Chem. 42 (2007) 125-137; DOI: 10.1016/j.ejmech.2006.09.019. C. N. Khobragade, R. G. Bodade, M. S

Open access

José A. S. Luis, Thiago M. De Aquino, Bruno F. Lira, Petrônio F. A. Filho, Marcus T. Scotti, Luciana Scotti, Ricardo O. De Moura and Francisco J. B. Mendonça Junior

References 1. L. B. Kier and E. B. Roche, Medicinal chemistry of the mesoionic compounds, J. Pharm. Sci. 56 (1966) 149-168; DOI: 10.1002/jps.2600560202. 2. M. B. Oliveira, J. Miller, A. B. Pereira, S. E. Galembeck, G. L. C. Moura and A. M. Simas, Mesoionic 2-N-cycloalkylamino-5-alkyl-1,3-dithiolium-4-thiolates, Phosphorus, Sulfur, Silicon Relat. Elem. 108 (1996) 75-84; DOI: 10.1080/10426509608029640. 3. C. A. C. Bosco, G. S. Maciel, N. Rakov, C. B. Araújo, L. H. Acioli, A. M. Simas, P. F. Athayde- -Filho and J

Open access

Eslam El-Sawy, Adel Mandour, Khaled Mahmoud, Inas Islam and Heba Abo-Salem

, Synthesis and characterization of some chalcones and their cyclohexenone derivatives, Central Eur. J. Chem.   8 (2010) 174-181; DOI: 10.2478/s11532-009-0124-x. S. George, M. P. Waran, A. Chakraborty and T. K. Ravi, Synthesis and evaluation of the biological activities of some 3-[5-(6-methyl-4-aryl-2-oxo-1,2,3,4-tetrahydropyrimidin-5-yl)-1,3,4-oxadiazol-2-yl]-imino-1,3-di-hydro-2 H -indol-2-one derivatives, Acta Pharm.   58 (2008) 119-129; DOI: 10.2478/v10007-007-0050-4. A. H. Mandour, E. R. El-Sawy, K. H. Shaker and

Open access

Mostafa M. Ghorab, Mahmoud S. Bashandy and Mansour S. Alsaid

, and thermal studies, J. Coordination Chem. 61 (2008) 2053-2067; DOI: 10.1080/00958970701862167. 13. S. S. Mohamed, S. A. Mohamed, E. S. Shalfoh and O. Fhid, Microwave assisted one-pot synthesis and screening of some schiff’s bases of sulfanilamide, J. Chem. Pharmaceutical. Res. 4 (2012) 2512-2516; DOI: 5-2012/JCPR-2012-4-5-2512-2516. 14. G. D. Simone and C. T. Supuran, Carbonic anhydrase IX: Biochemical and crystallographic characterization of a novel antitumor target, Biochim. Biophys. Acta 1804 (2010) 404-409; DOI: 10.1016/j. bbapap

Open access

Mohammed Albratty, Karam Ahmed El-Sharkawy and Shamsher Alam

, Design and synthesis of new 3-(benzo [d] isoxazol-3yl)-1-substituted pyrrolidine-2,5-dione derivatives as anti-convulsants, Eur. J. Med. Chem. 84 (2014) 42-50; DOI: 10.1016/j.ejmech.2014.07.016 13. P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. McMahon, D. Vistica, J. T. Warren, H. Bokesch, S. Kenney and M. R. Boyd, New colorimetric cytotoxicity assay for anticancer-drug screening, J. Natl. Cancer Inst. 82 (1990) 1107-1112; DOI: 10.1093/jnci/82.13.1107. 14. A. Monks, D. Scudiero, P. Skehan, R. Shoemaker, K. Paull, D

Open access

Mostafa M. Ghorab and Mansour S. Alsaid

and R. A. Kumar, New 1,3-oxazolo [4,5- c ] quinoline derivatives: Synthesis and evaluation of antibacterial and antituberculosis properties, Eur. J. Med. Chem. 45 (2010) 957–966; DOI: 10.1016/j.ejmech.2009.11.036. 7. M. Hranjec, M. Kralj, I. Piantanida, M. Sedic, L. Šuman, K. Pavelic and G. Karminski-Zamola, Novel cyano- and amidino-substituted derivatives of styryl-2-benzimidazoles and benzimidazo[1,2- a ] quinolines. Synthesis, photochemical synthesis, DNA binding, and antitumor evaluation, part 3, J. Med. Chem . 50 (2007) 5696–5711; DOI: 10.1021/jm

Open access

Čižmáriková R., Némethy A., Valentová J., Hroboňová K. and Adamcová K.

;67:113-117. [11] Čižmarikova R, Polakovičova M, Mišikova E. Synthesis, physicochemical properties and conformational studies of (3-chloromethyl-4-hydroxyphenyl)ethanones. Chem Papers. 2002;56:256-260. [12] Čižmarikova R, Račanska E, Hroboňova K, Lehotay J, Mišikova E. Synthesis and enantioseparation od some aryloxyaminopropanol derivatives and their effect on the central nervous system. Acta Facult Pharm Univ Comenianae. 2003;50:38-50. [13] Čižmarikova R, Nemethy A, Valentova J, Hroboňova K, Bruchata K. Synthesis and HPLC enantioseparation of

Open access

R. Čižmáriková, A. Némethy, J. Valentová, K. Hroboňová and K. Bruchatá

local anesthetics, hypotensives, and tranquilizers. J Med Chem. 1973;16:797-804. Sharma SC, Evans MB, Evans SJ. The enantiomeric separation of metipranolol and desacetylmetipranolol on a cellulose tris-3,5-dimethylphenylcarbamate chiral stationary phase. J Pharm Biomed Anal. 1995;13:129-137. Valentova J, Čižmarikova R, Bui TTT, Drake AF, Hutt AJ. Enantiomeric resolution of novel aryloxyaminopropanol derivatives with β-adrenoceptor antagonist activity on a derivatised amylose chiral stationary phase. Chromatographia. 2003

Open access

B. Kováčová, J. Hasilla and A. Ďurišová

References [1] AHRQ. Reducing and preventing adverse drug events to decrease hospital costs. (http://www.ahrq.gov/research/findings/factsheets/errors-safety/aderia/index.html#Introduction). Accessed February 10, 2013. [2] Bergk V et al. Information deficits in the summary of product characteristics preclude an optimal management of drug interactions: A comparison with the evidence from the literature. Eur J Clin Pharmacol. 2005; 61(5-6): 327-335. [3] Buck TC, Brandstrup L, Brandslund I, Kampmann JP. The effects

Open access

Eman M. Flefel, Randa E. Abdel-Mageid, Waled A. Tantawy, Mohamed A. Ali and Abd El-Galil E. Amr

S. Yoon, 1,3-Diphenyl-1 H -pyrazole derivatives as a new series of potent PPARg partial agonists, Bioorg. Med. Chem. 18 (2010) 8315-8323; DOI: 10.1016/j.bmc.2010.09.068. 6. A. Mohammad, K. Harish and S. A. Javed, Pharmacological activities of pyrazole and its derivatives , Hamdard Medicus 52 (2009) 102-118. 7. A. El Maatougui, J. Azuaje, E. Sotelo, O. Caamaño and A. Coelho, Silica-supported aluminum chloride-assisted solution phase synthesis of pyridazinone-based antiplatelet agents , ACS Comb. Sci. 10 (2011) 7